Helen Luikart

4.4k total citations · 1 hit paper
97 papers, 2.8k citations indexed

About

Helen Luikart is a scholar working on Surgery, Transplantation and Biomedical Engineering. According to data from OpenAlex, Helen Luikart has authored 97 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Surgery, 49 papers in Transplantation and 24 papers in Biomedical Engineering. Recurrent topics in Helen Luikart's work include Transplantation: Methods and Outcomes (85 papers), Renal Transplantation Outcomes and Treatments (47 papers) and Mechanical Circulatory Support Devices (24 papers). Helen Luikart is often cited by papers focused on Transplantation: Methods and Outcomes (85 papers), Renal Transplantation Outcomes and Treatments (47 papers) and Mechanical Circulatory Support Devices (24 papers). Helen Luikart collaborates with scholars based in United States, Canada and South Korea. Helen Luikart's co-authors include Hannah A. Valantine, Kiran K. Khush, Iwijn De Vlaminck, Daniel Bernstein, Calvin Strehl, Stephen R. Quake, Jennifer Okamoto, Norma Neff, Thomas M. Snyder and Garrett Cohen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Helen Luikart

86 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection

2014 372 citations Iwijn De Vlaminck, Hannah A. Valantine et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Luikart United States	26	1.6k	1.0k	582	454	443	97	2.8k
David Weill United States	31	3.0k 1.9×	1.1k 1.1×	881 1.5×	227 0.5×	183 0.4×	79	4.3k
Marie Budev United States	33	2.2k 1.4×	759 0.8×	792 1.4×	268 0.6×	39 0.1×	180	3.6k
Stuart C. Sweet United States	36	2.7k 1.7×	1.1k 1.1×	712 1.2×	218 0.5×	40 0.1×	124	3.9k
R. Guillemain France	26	1.2k 0.7×	577 0.6×	543 0.9×	271 0.6×	18 0.0×	118	2.4k
Jim Egan Ireland	30	1.2k 0.8×	251 0.3×	750 1.3×	289 0.6×	54 0.1×	101	4.0k
Paul Gibbs United Kingdom	28	1.3k 0.8×	473 0.5×	669 1.1×	119 0.3×	35 0.1×	94	2.7k
John R. Greenland United States	24	668 0.4×	272 0.3×	284 0.5×	68 0.1×	19 0.0×	99	1.6k
Frank P. Stuart United States	30	1.2k 0.7×	1.1k 1.1×	553 1.0×	75 0.2×	14 0.0×	108	3.0k
Roman Zachoval Germany	39	442 0.3×	142 0.1×	3.9k 6.6×	114 0.3×	54 0.1×	138	6.4k
Urban Sester Germany	38	520 0.3×	271 0.3×	1.7k 2.9×	87 0.2×	23 0.1×	99	3.7k

Countries citing papers authored by Helen Luikart

Since Specialization

Citations

This map shows the geographic impact of Helen Luikart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Luikart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Luikart more than expected).

Fields of papers citing papers by Helen Luikart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Luikart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Luikart. The network helps show where Helen Luikart may publish in the future.

Co-authorship network of co-authors of Helen Luikart

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Luikart. A scholar is included among the top collaborators of Helen Luikart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Luikart. Helen Luikart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Christopher, L. Dawson, Pascal Thériault-Lauzier, et al.. (2025). Repeatability and Correlation of Coronary Physiology Indices Measured With Bolus and Continuous Thermodilution. Circulation Cardiovascular Interventions. 18(4). e014919–e014919.

Kong, Heidi H., Helen Luikart, T. Intrieri, et al.. (2025). Levels of Cell-free DNA at the Diagnosis of Antibody-mediated Rejection Predict Poor Outcomes in Lung Transplant Recipients. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3341–A3341.

Hollander, Seth A., et al.. (2025). Fifty Year Outcomes After Pediatric Heart Transplantation: A Pediatric-Adult Center Linked Analysis. The Journal of Heart and Lung Transplantation. 44(4). S232–S233.

Sánchez, Miguel, Chang Chen, Fernando del Castillo, et al.. (2024). Cutting to the Bone: Impact of Redo Sternotomy on Outcome of Adult Heart Transplant. The Journal of Heart and Lung Transplantation. 43(4). S571–S572.

Keller, Michael, Yang Song, A. Cochrane, et al.. (2023). Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death. American Journal of Transplantation. 23(4). 559–564. 16 indexed citations

Cochrane, A., Deborah J. Levine, Mary Carmelle Philogene, et al.. (2022). Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories. The Journal of Heart and Lung Transplantation. 42(2). 226–235. 8 indexed citations

Moayedi, Yasbanoo, Helen Luikart, Jiho Han, et al.. (2022). Combining donor derived cell free DNA and gene expression profiling for non‐invasive surveillance after heart transplantation. Clinical Transplantation. 37(3). e14699–e14699. 15 indexed citations

Moayedi, Yasbanoo, Farid Foroutan, Robert J.H. Miller, et al.. (2018). Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients. The Journal of Heart and Lung Transplantation. 38(1). 51–58. 31 indexed citations

Fearon, William F., Kozo Okada, Jon Kobashigawa, et al.. (2017). Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation. Journal of the American College of Cardiology. 69(23). 2832–2841. 42 indexed citations

10.

Okada, Kozo, William F. Fearon, Helen Luikart, et al.. (2016). Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation. Journal of the American College of Cardiology. 68(4). 382–392. 14 indexed citations

11.

Kitahara, Hideki, Kozo Okada, Shigemitsu Tanaka, et al.. (2016). Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients. The Journal of Heart and Lung Transplantation. 35(6). 752–759. 8 indexed citations

12.

Vlaminck, Iwijn De, Kiran K. Khush, Calvin Strehl, et al.. (2013). Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy. Cell. 155(5). 1178–1187. 337 indexed citations

13.

Holweg, Cécile, Luciano Potena, Helen Luikart, et al.. (2011). Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptional Profiling. Circulation. 123(20). 2236–2243. 26 indexed citations

14.

Yamasaki, Masao, Ryota Sakurai, Atsushi Hirohata, et al.. (2011). Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings by Three-Dimensional Intravascular Ultrasound Analysis. Transplantation. 91(12). 1406–1411. 15 indexed citations

15.

Potena, Luciano, William F. Fearon, Karsten Sydow, et al.. (2008). Asymmetric Dimethylarginine and Cardiac Allograft Vasculopathy Progression. Transplantation. 85(6). 827–833. 16 indexed citations

16.

Fearon, William F., Atsushi Hirohata, Mamoo Nakamura, et al.. (2006). Discordant Changes in Epicardial and Microvascular Coronary Physiology After Cardiac Transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) Study. The Journal of Heart and Lung Transplantation. 25(7). 765–771. 63 indexed citations

17.

DeCampli, William M., Helen Luikart, Sharon Hunt, & Edward B. Stinson. (1995). Characteristics of patients surviving more than ten years after cardiac transplantation. Journal of Thoracic and Cardiovascular Surgery. 109(6). 1103–1115. 41 indexed citations

18.

Kuo, Paul C., Helen Luikart, Hannah A. Valantine, et al.. (1995). Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. Clinical Transplantation. 9(2). 92–97. 11 indexed citations

19.

Starnes, Vaughn A., Norman J. Lewiston, Helen Luikart, et al.. (1992). Current trends in lung transplantation. Journal of Thoracic and Cardiovascular Surgery. 104(4). 1060–1066. 60 indexed citations

20.

Starnes, Vaughn A., Norman J. Lewiston, Helen Luikart, et al.. (1992). Current trends in lung transplantation. Lobar transplantation and expanded use of single lungs.. PubMed. 104(4). 1060–5; discussion 1065. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact